We have tracked, categorized under Education, Health, over 1 funding programs and $2,500,000 allocated funding to date.
Recent published funding opportunities:
| Funding Opportunity |
Mechanisms of Reciprocal Interactions between HIV Associated Neuroinflammation and CNS Persistence: Implications in HIV Neuropathogenesis and Cure (R01 Clinical Trial Not Allowed) Apply for RFA MH 25 180
Funding Number: RFA MH 25 180
Agency: National Institutes of Health
Funding Amount: Case Dependent |
Treatments for Lewy Body Dementias and Frontotemporal Dementias--Exploratory Clinical Trial (U01 Clinical Trial Required) Apply for RFA NS 22 056
Funding Number: RFA NS 22 056
Agency: National Institutes of Health
Funding Amount: $400,000 |
Patient Derived Xenograft (PDX) Development and Trial Centers (PDTCs) Network (U54 Clinical Trial Not Allowed) Apply for RFA CA 22 012
Funding Number: RFA CA 22 012
Agency: National Institutes of Health
Funding Amount: Case Dependent |
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional) Apply for RFA CA 22 010
Funding Number: RFA CA 22 010
Agency: National Institutes of Health
Funding Amount: $150,000 |
Strengthening the Impact of Community Health Workers on the HIV Care Continuum in the US (R01 Clinical Trial Optional) Apply for RFA NR 20 002
Funding Number: RFA NR 20 002
Agency: National Institutes of Health
Funding Amount: $500,000 |
Exploring Epigenomic or Non-Coding RNA Regulation in the Development, Maintenance, or Treatment of Chronic Pain (R61/R33 Clinical Trial Optional) Apply for PAR 18 742
Funding Number: PAR 18 742
Agency: National Institutes of Health
Funding Amount: Case Dependent |
Revision Applications to National Cancer Institute (NCI)-supported P50 Awards to Include Research on the NCIs Provocative Questions (P50 Clinical Trial Optional) Apply for RFA CA 18 024
Funding Number: RFA CA 18 024
Agency: National Institutes of Health
Funding Amount: $150,000 |
NIDA Program Project Grant Applications (P01, Clinical Trial Optional) Apply for PAR 18 425
Funding Number: PAR 18 425
Agency: National Institutes of Health
Funding Amount: Case Dependent |
Innovations in Mechanisms and Interventions to Address Mental Health in HIV Prevention and Care Continuum (R01 Clinical Trial Optional) Apply for PA 18 274
Funding Number: PA 18 274
Agency: National Institutes of Health
Funding Amount: Case Dependent |
Research Centers for Population-based Research to Optimize Cancer Screening (PROSPR) Initiative (UM1) Apply for RFA CA 16 016
Funding Number: RFA CA 16 016
Agency: Department of Health and Human Services, National Institutes of Health
Funding Amount: $2,500,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
